Previous COVID-19 vaccines have induced robust IgG and IgA levels against SARS-CoV-2 antigens, dominated by IgG1 and IgG3 responses, responsible for FcγR-mediated effector functions33–35. The gene discussed is CD79A; the disease is COVID-19.